Published in Cancer on December 01, 1988
Patients with metastatic renal carcinoma candidate for immunotherapy with cytokines. Analysis of a single institution study on 181 patients. Br J Cancer (1993) 0.86
Intravenous interleukin-2 in patients over 65 with metastatic renal carcinoma. Br J Cancer (1992) 0.79
Metastatic renal cell cancer--is the outlook really improving? Postgrad Med J (1990) 0.75
Ifosfamide, vindesine and recombinant alpha-interferon combination chemotherapy for metastatic renal cell carcinoma. J Cancer Res Clin Oncol (1991) 0.75
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect (2012) 4.56
A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer (1981) 4.25
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update. Bone Marrow Transplant (2010) 3.46
5-Fluorouracil versus 5-fluorouracil plus alpha-interferon as treatment of metastatic colorectal carcinoma. A randomized study. Ann Oncol (1996) 3.10
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis (1997) 2.78
Frequent factor II G20210A mutation in idiopathic portal vein thrombosis. Gastroenterology (1999) 2.66
Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother (2006) 2.65
Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials. Br J Cancer (2004) 1.94
Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs. J Clin Oncol (1991) 1.94
Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections. Br J Haematol (1998) 1.84
An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group. J Infect (1998) 1.82
An electron microscopy study into the mechanism of gene transfer with lipopolyamines. Gene Ther (1996) 1.75
A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. Br J Haematol (1997) 1.59
Factors determining the specificity of the tRNA aminoacylation reaction. Non-absolute specificity of tRNA-aminoacyl-tRNA synthetase recognition and particular importance of the maximal velocity. Biochimie (1973) 1.56
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clin Microbiol Infect (2012) 1.55
Control of the antitumoral activity of human macrophages produced in large amounts in view of adoptive transfer. Eur J Cancer Clin Oncol (1988) 1.52
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. Clin Microbiol Infect (2012) 1.48
Emphysematous pyelitis: findings in five patients. Radiology (2001) 1.47
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect (2012) 1.41
Case report: Mesenteric lipodystrophy associated with renal cell carcinoma: imaging findings. Clin Radiol (1998) 1.40
[Current treatments of cancer of the prostate]. Presse Med (1991) 1.38
Theories of endometriosis. Eur J Obstet Gynecol Reprod Biol (2001) 1.34
Forty-one recent cases of invasive zygomycosis from a global clinical registry. J Antimicrob Chemother (2009) 1.31
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte). Ann Oncol (1993) 1.29
Properties of reference Escherichia coli endotoxin and its phthalylated derivative in humans. J Infect Dis (1981) 1.27
Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma. J Clin Oncol (1996) 1.26
Acquired c1-inhibitor deficiencies in lymphoproliferative diseases with serum immunoglobulin abnormalities. A study of three cases. Blut (1976) 1.25
Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial. Br J Cancer (2006) 1.22
Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment. Hematol J (2001) 1.20
Towards novel paradigms for cancer therapy. Oncogene (2010) 1.18
Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group. Clin Infect Dis (1997) 1.17
Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles--initial clinical experience. Radiology (1998) 1.17
Candida catenulata fungemia in a cancer patient. J Clin Microbiol (1999) 1.17
A retrospective series of gut aspergillosis in haematology patients. Clin Microbiol Infect (2011) 1.13
Superselective endo-vascular treatment of renal vascular lesions. J Urol (1995) 1.10
Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability. Transpl Infect Dis (1999) 1.09
Treatment of acquired C1-inhibitor deficiency with danazol. Ann Intern Med (1977) 1.07
Rituximab versus observation after high-dose consolidative first-line chemotherapy with autologous stem-cell transplantation in patients with poor-risk diffuse large B-cell lymphoma. Ann Oncol (2009) 1.07
Biclonal and biallelic deletions occur in 20% of B-ALL cases with IKZF1 mutations. Leukemia (2012) 1.07
Aggressive primary gastrointestinal lymphomas: review of 91 patients treated with the LNH-84 regimen. A study of the Groupe d'Etude des Lymphomes Agressifs. Am J Med (1991) 1.05
Radical nephrectomy with and without lymph node dissection: preliminary results of the EORTC randomized phase III protocol 30881. EORTC Genitourinary Group. Eur Urol (1999) 1.04
Combined modality treatment for malignant transformation of a benign ovarian teratoma. Gynecol Oncol (1999) 1.04
The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses. Clin Infect Dis (1995) 1.03
Bone marrow necrosis. acute microcirculation failure in myelomonocytic leukemia. Arch Intern Med (1978) 1.02
Sodium dithiocarb as adjuvant immunotherapy for high risk breast cancer: a randomized study. Biotherapy (1993) 1.02
Natural history of residual renal stone fragments after ESWL. Eur Urol (2000) 1.02
Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte. Br J Cancer (1994) 1.01
LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. J Clin Oncol (1989) 1.01
Fatal dissection of the pulmonary artery in pulmonary arterial hypertension. Eur Respir Rev (2009) 1.00
Fetal macrosomia: risk factors and outcome. A study of the outcome concerning 100 cases >4500 g. Eur J Obstet Gynecol Reprod Biol (1998) 0.99
Improvement in the outcome of invasive fusariosis in the last decade. Clin Microbiol Infect (2013) 0.99
Mixed-lymphocyte reaction as assay for immunological competence of lymphocytes from patients with hodgkin's disease. Lancet (1972) 0.98
[Atypical metastatic site of lung adenocarcinoma]. Rev Pneumol Clin (2011) 0.98
Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections. J Infect (2006) 0.97
Antiphospholipid syndrome and recurrent miscarriages. Eur J Obstet Gynecol Reprod Biol (2001) 0.96
An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients. J Antimicrob Chemother (2009) 0.96
Long term cultures of human monocytes in vitro. Impact of GM-CSF on survival and differentiation. J Immunol Methods (1991) 0.96
Saccade metrics in multiple sclerosis: versional velocity disconjugacy as the best clue? J Neurol Sci (1991) 0.96
[Trichosporon capitatum septicemia in immunosuppressed patients]. Pathol Biol (Paris) (1990) 0.95
Disseminated Trichosporon capitatum infection in a patient with acute leukemia undergoing bone marrow transplantation. Bone Marrow Transplant (1990) 0.95
Linear degrees of freedom in speech production: analysis of cineradio- and labio-film data and articulatory-acoustic modeling. J Acoust Soc Am (2001) 0.95
Efficiency of a phase 1 vaccine for the reduction of vaginal Coxiella burnetii shedding in a clinically affected goat herd. Clin Microbiol Infect (2009) 0.94
E-cadherin mRNA expression in breast carcinomas correlates with overall and disease-free survival. Invasion Metastasis (1996) 0.93
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases. Clin Microbiol Infect (2012) 0.93
Invasive aspergillosis as an opportunistic infection in nonallografted patients with multiple myeloma: a European Organization for Research and Treatment of Cancer/ Invasive Fungal Infections Cooperative Group and the Intergroupe Français du Myélome. Clin Infect Dis (2000) 0.93
Unfaithfulness and promiscuity of a mutant androgen receptor in a hormone-refractory prostate cancer. Cell Mol Life Sci (2006) 0.92
Effect of pristinamycin on cyclosporin levels in bone marrow transplant recipients. Bone Marrow Transplant (1989) 0.92
Blood ketone monitoring: a comparison between gestational diabetes and non-diabetic pregnant women. Diabetes Metab (2006) 0.92
Latent acute promyelocytic leukemia t(15;17)(q22;q12-21) and sarcoidosis: long-term cohabitation. Eur J Intern Med (2005) 0.92
Seroprevalence of Q fever (coxiellosis) in sheep from the Southern Marmara Region, Turkey. Comp Immunol Microbiol Infect Dis (2008) 0.92
Epidemiological study of invasive pulmonary aspergillosis in a haematology unit by molecular typing of environmental and patient isolates of Aspergillus fumigatus. J Hosp Infect (2005) 0.91
[Application of cytochemical methods to 47 cases of acute leukemia. Cytochemical chages during development]. Sem Hop (1973) 0.91
Immunological aspects of endometriosis. Hum Reprod Update (2005) 0.91
Adhesive and/or signaling functions of CD44 isoforms in human dendritic cells. J Immunol (1998) 0.91
Human resident peritoneal macrophages: phenotype and biology. Br J Haematol (1994) 0.90
Detection of prostate-specific antigen- or prostate-specific membrane antigen-positive circulating cells in prostatic cancer patients: clinical implications. Eur Urol (1999) 0.89
Caspase-3-like activity determines the type of cell death following ionizing radiation in MOLT-4 human leukaemia cells. Br J Cancer (2000) 0.89
Benign hyperplasia in ectopic prostatic tissue: a rare cause of pelvic mass. Eur Radiol (1997) 0.89
Otological manifestations of acute leukaemia: report of two cases and review of literature. Clin Lab Haematol (2001) 0.89
Progression of Q fever and Coxiella burnetii shedding in milk after an outbreak of enzootic abortion in a goat herd. Vet Rec (2005) 0.89
Phase I study of liposomal MTP-PE-activated autologous monocytes administered intraperitoneally to patients with peritoneal carcinomatosis. J Clin Oncol (1991) 0.89
Baseline nutritional status is prognostic factor after definitive radiochemotherapy for esophageal cancer. Dis Esophagus (2012) 0.88
Single stones of the lower pole of the kidney. Comparative results of extracorporeal shock wave lithotripsy and percutaneous nephrolithotomy. Eur Urol (1998) 0.88
Chronic disseminated Trichosporon asahii infection in a leukemic child. Clin Infect Dis (2002) 0.88
[Choroid plexus cysts and risks of chromosome anomalies. Review of the literature and proposed management]. J Gynecol Obstet Biol Reprod (Paris) (1998) 0.88
[Vaginal metastasis from cancer of the kidney]. Prog Urol (1994) 0.87
Mitochondrial DNA diversity in wild and cultivated sorghum. Genome (1995) 0.87
Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma: results of a European multi-center phase III study. Ann Oncol (1992) 0.87
No loss of genomic imprinting of IGF-II and H19 in placentas of diabetic pregnancies with fetal macrosomia. Growth Horm IGF Res (2007) 0.87
Immunological aspects of ovarian function: role of the cytokines. Eur J Obstet Gynecol Reprod Biol (1995) 0.87
Delayed elimination of methotrexate associated with co-administration of proton pump inhibitors. Anticancer Res (2010) 0.87
Microscopic venous invasion: a prognostic factor in renal cell carcinoma. Eur Urol (2000) 0.87
European expert opinion on the management of invasive candidiasis in adults. Clin Microbiol Infect (2011) 0.87
CD44 exon 6 expression as a possible early prognostic factor in primary node negative breast carcinoma. Clin Exp Metastasis (1996) 0.87
MR urography in the evaluation of urinary tract obstruction. Abdom Imaging (1998) 0.86